As Vice-Chair, Orla will play a lead role in crafting the updated Aspergillosis Clinical Practice Guidelines. The Aspergillosis guidelines were first published in 2008 and updated in 2016. These guidelines are internationally recognised and regularly used by clinicians the world over. The guidelines have been cited 1862 times since 2016.
Showing posts with label Orla Morrissey. Show all posts
Showing posts with label Orla Morrissey. Show all posts
1 Mar 2022
Congratulations to Professor Orla Morrissey on prestigious appointment
Congratulations to Professor Orla Morrissey, who has been selected by the Infectious Diseases Society of America (IDSA) Executive Committee and the Standard and Practice Guideline Committee (SPGC) Leadership of IDSA as Vice-Chair of the IDSA Aspergillosis Guideline Panel.
21 Jun 2021
Orla Morrissey recognised as thought leader in transplant infectious diseases research
Congratulations to Professor Orla Morrissey who has been appointed as an Associate Editor of the American Journal of Transplantation. The journal is ranked 2 in transplantation and 6 in Surgery with over two million downloads per year.
Prof Morrissey has been recognised most recently by the World Health Organisation, which has provided funding for antifungal stewardship to develop the Fungal Priority Pathogen List.
See more about Prof Morrissey's research here:
https://www.monash.edu/medicine/ccs/infectious-diseases/research/groups/morrissey_group
11 Feb 2021
Prof Orla Morrissey wins WHO funding for antifungal stewardship
| Professor Orla Morrissey |
31 Jan 2020
Immune recovery can be precisely measured: Infectious Diseases research wins award
| Professor Orla Morrissey |
The paper, which appeared in Clinical & Translational Immunology in October 2018, was one of two that received awards for Society publications at the conference. The honours recognise the most outstanding articles based on scientific merit published in the previous year.
15 Feb 2017
Photo of the week: Dr Orla Morrissey
![]() |
| Dr Orla Morrissey presented at the CCS Monash Department of Infectious Diseases' highly successful advanced course (200 attendees) on Infections in the Immunocompromised Host last year. Along with Professor Anton Peleg, Orla set up and widely promoted the course to infectious diseases specialists around Australia. |
- Skov Dalgaard L, Nørgaard M, Povlsen JV, Morrissey O, Jespersen B, Jensen-Fangel S, Østergaard LJ, Schønheyder HC, Søgaard OS. Risk and prognosis of bacteremia and fungemia among first-time kidney transplant recipients: a population-based cohort study. Infect Dis (Lond). 2017 Apr;49(4):286-295. doi: 10.1080/23744235.2016.1248483. Epub 2016 Nov 8.
11 Oct 2016
Infectious Diseases inaugural course a runaway success!
![]() |
| Prof Jay Fishman speaking at the course |
The course was born of the infectious diseases physician-researchers' clinical experience of managing immuno-compromised patients, including those suffering from cancer, those who have had transplants, and those taking monoclonal therapies, and the need to incorporate the most recent research findings into patient management.
![]() |
| Capacity audience for the course |
23 Sept 2013
Department of Infectious Diseases research is top rated by international peers
![]() |
| A/Prof Edwina Wright |
Subscribe to:
Posts (Atom)




